Deep Genomics’ Post

So yeah, 10 years at 10x Genomics! For those wondering what it's like to work at the same company for a decade, well I can’t say I know, because 10x has hardly been the same company over this period of time! The company grew so much over the years to tackle the increasing complexity of the technologies that we develop. This leads to increasingly growing opportunities to expand one's horizons, keep discovering and learning from others, and keep rising to new challenges and aspirations. The secret sauce? 10x's super power lies in bringing together a world class #team of scientists and professionals with diversified backgrounds, and fostering genuine #collaboration to fuel #innovation and the creative design and development of novel robust technologies. Seeing these tools empower the scientific community and contribute to the #discovery of disease attributes, developmental pathways and immunological fundamentals is so fulfilling, exhilarating and humbling. I am so fortunate to be part of this incredible journey, and I can only look forward to the next decade to continue accelerating the mastery of biology to advance human health.

🤝 𝗠𝗲𝗲𝘁 𝗼𝘂𝗿 𝘁𝗲𝗮𝗺 𝗮𝘁 𝗡𝗲𝘅𝘁𝗚𝗲𝗻 𝗢𝗠𝗜𝗖𝗦 𝟮𝟬𝟮𝟰 𝗶𝗻 𝗟𝗼𝗻𝗱𝗼𝗻!🇬🇧   From October 23-25, 2024, Volodimir Olexiouk - director of scientific engagement,  Andrea Del Cortona - lead data scientist & innovation manager, and Amparo Cuéllar - business development director, will be in London joining the world's top omics research experts.   We'll be discussing the latest advancements in multi-omics research and how BioLizard can help you unlock value in data integration – whether you're working on single-cell, spatial analytics, or drug discovery.   Let’s connect if you’re interested in:  🔍 Improving targeted identification  🩺 Understanding the mode of action between disease and health  📊 Integrating and analysing multi-omics in your research   We’re excited to showcase our exciting new tools:  🪐 Bio|Verse – 𝗔 𝗳𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸 𝗳𝗼𝗿 𝘃𝗶𝘀𝘂𝗮𝗹𝗶𝘀𝗶𝗻𝗴 𝗮𝗻𝗱 𝗻𝗮𝘃𝗶𝗴𝗮𝘁𝗶𝗻𝗴 𝗰𝗼𝗺𝗽𝗹𝗲𝘅 𝗱𝗮𝘁𝗮𝘀𝗲𝘁𝘀 🤖 Bio|Mx– 𝗔𝗜-𝗱𝗿𝗶𝘃𝗲𝗻 𝗱𝗮𝘁𝗮 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗮𝗻𝗱 𝗺𝘂𝗹𝘁𝗶-𝗼𝗺𝗶𝗰𝘀 𝗶𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗶𝗼𝗻   Coupled with our custom bioinformatics services we can bridge the gap from data to insights.   Are you attending? We'd love to connect and show you how these tools can transform your research! #multiomics #diagnosticsapproaches #clinicalgenomics #datascience #bioinformatics #targetedvalidation #drugdevelopment #drugdiscovery

Come to meet us from tomorrow to Friday at 𝗡𝗲𝘅𝘁𝗚𝗲𝗻 𝗢𝗠𝗜𝗖𝗦 𝟮𝟬𝟮𝟰 𝗶𝗻 𝗟𝗼𝗻𝗱𝗼𝗻. Looking forward to discuss the latest advances on target and biomarkers discovery, and to integrate clinical omics data to derisk and accelerate your drug discovery pipeline! #multiomics #diagnosticsapproaches #clinicalgenomics #datascience #bioinformatics #targetedvalidation #drugdevelopment #drugdiscovery

🤓 Nerd Alert @ the inbiome HQ 🤓 Take a quick peak at the weekly research gathering of our team! Each thursday morning all team divisions (IT, R&D, QA, Lab Operations, Commercial, Leadership) sit in one room to explore together either our own research questions or interesting science around us. While two weeks ago we discussed the latest experiments of one the sample types we are studying, today our founders brought us the freshest bits from the ASM Microbe Conference in Atlanta. New technologies, potential partnerships...so much inspiration to keep on radically accelerating human healthcare 🚀 #inbiome #MolecularCulture #fastdiagnostics #nerdalert

We all know times can be tough, and as a business leader it's what you do when the chips are down that really makes your reputation. Whilst Bionano are reducing their workforce, it would be all too easy to just leave it there. Neil has instead taken to LinkedIn to find new roles for the great team they are unfortunately having to let go. Great example to set. Please share his original message to make sure these people are snapped up quickly. #Leadership #LifeSciences

Here's a post I'd hoped never to have to make. After more than 2 amazing years at Slingshot Biosciences, my position (along with an unfortunate number of amazing coworkers) was eliminated in a #strategicreorganization. While still shocked about the #layoff, I  am intensely proud of what we accomplished against incredible odds. I could not have asked for a better environment to grow into my first commercial role and am so grateful to the many awesome people who made my time at Slingshot such a joy. I learned so much about #flowcytometry, #celltherapy, #biologics, #mRNAvaccines, #analyticaldevelopment, #startups, and most importantly how much I loved working with our many wonderful clients, collaborators, and friends. One skill I developed at Slingshot for situations like this is to take a deep breath, identify my goals, prioritize the next steps, and move forward. As such I’m now #opentowork and am looking for #sales, #businessdevelopment, #scientificaffairs, #applicationscience, or similar roles where I can use my #passion for flow cytometry, #immunology, and #science to support cutting-edge cures. If you’ve stayed with me this far and want to help, thank you! Here’s how: 1. If we had positive interactions, please make a recommendation on my profile highlighting what you enjoyed about our time together so future colleagues can get a clearer picture of what I have to offer. 2. If you know of a role that might be a fit for me or any of my affected colleagues, please send it my way. 3. Check out my profile on biobuzz.io or my AMA (see below). 4. Keep an eye out for my upcoming blog/newsletter covering topics in assay development, cytometry, and whatever else I find interesting. 5. Keep in touch! One of the best parts of my time at Slingshot was meeting all of you awesome people. Thank you for reading; I know something amazing is waiting out there for me and I look forward to finding it! https://lnkd.in/eyhz3vvC

An increasing risk as a scientist/RA within biotech R&D is that if you do good science and the research works — you may soon be finding yourself out of a job. As an industry we’re often focused on founders but for bio to thrive we need an ecosystem where success for a company is also success for all those who work there. Are R&D layoffs after a successful trial just the new norm now? Seems like weird incentives to me for R&D teams https://lnkd.in/gjEzJeDK

'Mastering the intricacies of dsRNA detection' - Alpha, our newest intern, is not just learning; he's innovating from day one! Check out our blog to learn about his impactful work at Southern RNA and how we're committed to supporting the next generation of scientists in biotech. Your insights matter to us, so comment below and engage with the post to show your support emerging talent like Alpha! ➡️ https://bit.ly/48ojx3i #EmergingTalent #mRNATechnology #InnovationInScience #SouthernRNA

What action do you need to take when your startup is about to be hit with a flood of new data? Or maybe you’ve been tasked with building a data team from scratch within a larger organization... but how do you go about doing that? Success hinges on more than just handling data—it’s about building a strategy that can grow with your company, minimize inefficiencies, and set you up for long-term success. 👉 Join us at the next Buzzed for Biotech event 👈 Data & Drinks: Scaling Your Biotech Data Strategy October 24th Cambridge, MA RSVP here: https://lu.ma/dyjlfepo 🎙 We're excited to have Patrick O'Mara, Associate Director of Research Informatics at Photys Therapeutics, as a featured panelist. At Photys, Patrick leads the charge in creating advanced informatics platforms that support every stage of drug discovery. His deep expertise in building scalable data infrastructures, optimizing workflows, and ensuring seamless integration across teams makes him an invaluable resource for biotech leaders navigating similar challenges. If you’re looking to future-proof your data strategy and accelerate your research, this is the event you need to attend! I’ll be moderating the panel and representing dovetail biopartners. Special thanks to Ralf Felsner of Collaborative Drug Discovery - CDD Vault and John Masland of Pliancy for making this event possible. RSVP is required—limited spots available! #biotech #lifesciences #pharma #data #bioinformatics #networking

I want to talk to you about Viagra for a moment... Part of the Cambridge Future Tech mission is to turn unloved and overlooked deep-tech innovation into disruptive global ventures. What better example of a world-changing innovation that could have easily ended up on the cutting room floor than that of the little blue pill. Over twenty years ago, a medical laboratory stumbled upon an opportunity which happened to *ahem* present itself. Whilst lab testing a new drug designed to treat cardiovascular problems, some volunteers appeared curiously reluctant to report any changes – some flatly refused. When questioned, they coyly admitted to experiencing unexpected benefits in other parts of their anatomy. The research team refocused their goals and discovered that the test drug got hearts racing in a very different sense. Their adaptation to this market feedback would kick-start a global innovation success and would result in bringing in tens of billions in revenue. It was the perfect combination of scientific rigour with commercial common sense. This was the Viagra moment. But what will be the next? #deeptech #innovation